Cencora
Maureen Owens Goodrich is a seasoned executive with extensive experience in sales, account management, and strategic leadership within the healthcare and insurance industries. Currently serving as Senior Director of Strategic Accounts at AmerisourceBergen since February 2023, Maureen previously held the role of National Account Manager at Octapharma from February 2021 to February 2023. Prior to that, Maureen spent over 22 years at McKesson, including a notable tenure as Vice President of Sales for McKesson Health Systems, responsible for a revenue surpassing $4 billion across the New England and New York markets. Maureen also excelled as a Pharmacy Network Management leader at CIGNA Healthcare, where significant network growth was achieved, and as Director of Account Management at Travelers, where leadership skills in account management and financial underwriting were demonstrated. Maureen holds a Bachelor of Science in Political Science and Business from Boston College.
This person is not in any offices
Cencora
50 followers
Cencora, a company building on the legacy of AmerisourceBergen, is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We connect manufacturers, providers, and patients to ensure that anyone can get the therapies they need, where and when they need them. We also help our partners bring their innovations to patients more efficiently to accelerate positive outcomes. Becoming Cencora has allowed us to combine all the companies and services of AmerisourceBergen. Now, as a unified and internationally inclusive brand, we’re continuing to invest in and focus on our core pharmaceutical distribution business, while also growing our platform of pharma and biopharma services to support pharmaceutical innovation and access. Our 46,000+ worldwide team members are shaping the future of healthcare through the power of our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen, now Cencora, is ranked #10 on the Fortune 500 and #24 on the Global Fortune 500 with more than $230 billion in annual revenue.